KEY
31
2
JPM
59
-3
EQR
40
-4
EW
53
-2
STZ
54
2
CMCSA
39
-2
NUE
39
-4
BWA
49
-6
O
19
-12
MTCH
48
11
STX
42
-2
GME
54
-3
HIG
51
3
PVH
60
2
EXR
48
-3
ISRG
68
-3
SWKS
53
3
MLM
41
-2
NDAQ
50
-6
PGR
59
5
KEY
31
2
JPM
59
-3
EQR
40
-4
EW
53
-2
STZ
54
2
CMCSA
39
-2
NUE
39
-4
BWA
49
-6
O
19
-12
MTCH
48
11
STX
42
-2
GME
54
-3
HIG
51
3
PVH
60
2
EXR
48
-3
ISRG
68
-3
SWKS
53
3
MLM
41
-2
NDAQ
50
-6
PGR
59
5
Financhill
Back

Neumora Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
26

NMRA
Neumora Therapeutics

Last Price:
10.33
Seasonality Move:
43.48%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
26
Neumora Therapeutics (NMRA) is a Sell

Is Neumora Therapeutics a Buy, Sell or Hold?

  • The current Neumora Therapeutics [NMRA] share price is $10.32. The Score for NMRA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NMRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NMRA Stock Price Chart

What is Neumora Therapeutics's stock price today?

  • The Neumora Therapeutics share price today is $10.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NMRA is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

NMRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 44.82 Sell
Chaikin Money Flow: -283451 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.38 - 11.52) Sell
Bollinger Bands (100): (10.4 - 13.74) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

NMRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.24 Buy
20-day SMA: 10.01 Buy
50-day SMA: 12.13 Sell
200-day SMA: 11.78 Sell
8-day EMA: 10.29 Buy
20-day EMA: 10.45 Sell
50-day EMA: 11.27 Sell
200-day EMA: 12.17 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Neumora Therapeutics Earnings Growth & NMRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.07 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Neumora Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):